• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Why did VRX stock shoot up today?

Anonymous

Guest
Up $4 per share. With the news of Salix, isn't this the nail in the coffin? Everyone knows they desperately needed AGN to survive. I get why AGN shot up, but why did Valeant?
 




Up $4 per share. With the news of Salix, isn't this the nail in the coffin? Everyone knows they desperately needed AGN to survive. I get why AGN shot up, but why did Valeant?

Valeant needs acquisitions to survive. Salix would force them to drop going after AGN and find another deal. The market thinks this plan B is the better option.

It's win/win for Valeant and Allergan.